Description
IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - OPTION YEAR 3 FUNDING TASK ORDER - DECREASE EXCESS FUNDS
Base award description: IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - OPTION YEAR 3 FUNDING TASK ORDER
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-14+$423,875= $423,875
- Mod P000012016-04-12-$83,000= $340,875
- Mod P000022016-08-30-$134,684= $206,191
- Mod P000032016-12-07-$29,513= $176,678
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-14 | +$423,875 | $423,875 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - OPTION YEAR 3 FUNDING TASK ORDER |
| Mod P00001· FUNDING ONLY ACTION | 2016-04-12 | −$83,000 | $340,875 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - OPTION YEAR 3 FUNDING TASK ORDER - DECREASE EXCESS FUNDS |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2016-08-30 | −$134,684 | $206,191 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - OPTION YEAR 3 FUNDING TASK ORDER - DECREASE EXCESS FUNDS |
| Mod P00003· FUNDING ONLY ACTION | 2016-12-07 | −$29,513 | $176,678 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - OPTION YEAR 3 FUNDING TASK ORDER - DECREASE EXCESS FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0450 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $324,605 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
Other recipients under Q999 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626F0156 | BRANCH MEDICAL LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $157,170 | FY2026 |
| 36C25626D0074 | BRANCH MEDICAL LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626N0480 | LAREDO TECHNICAL SERVICES, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $634,046 | FY2026 |
| 36C25626D0045 | SS MEDICAL, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626D0037 | ROTECH HEALTHCARE INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25616J0018_3600_VA25612D0363_3600 · retrieved 2026-09-26.